These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein. Kellershohn N; Laurent M Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459 [TBL] [Abstract][Full Text] [Related]
3. The structure of human prions: from biology to structural models-considerations and pitfalls. Acevedo-Morantes CY; Wille H Viruses; 2014 Oct; 6(10):3875-92. PubMed ID: 25333467 [TBL] [Abstract][Full Text] [Related]
4. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases. Moreno JA; Telling GC Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793 [TBL] [Abstract][Full Text] [Related]
5. Prion protein conversion in vitro. Supattapone S J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886 [TBL] [Abstract][Full Text] [Related]
7. New insights into prion structure and toxicity. Harris DA; True HL Neuron; 2006 May; 50(3):353-7. PubMed ID: 16675391 [TBL] [Abstract][Full Text] [Related]
8. The state of the prion. Weissmann C Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743 [TBL] [Abstract][Full Text] [Related]
9. The role of rafts in the fibrillization and aggregation of prions. Pinheiro TJ Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049 [TBL] [Abstract][Full Text] [Related]
10. Non-genetic propagation of strain-specific properties of scrapie prion protein. Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905 [TBL] [Abstract][Full Text] [Related]
13. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro. Surewicz WK; Jones EM; Apetri AC Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682 [TBL] [Abstract][Full Text] [Related]
14. CD and NMR studies of prion protein (PrP) helix 1. Novel implications for its role in the PrPC-->PrPSc conversion process. Ziegler J; Sticht H; Marx UC; Müller W; Rösch P; Schwarzinger S J Biol Chem; 2003 Dec; 278(50):50175-81. PubMed ID: 12952977 [TBL] [Abstract][Full Text] [Related]
15. A general model of prion strains and their pathogenicity. Collinge J; Clarke AR Science; 2007 Nov; 318(5852):930-6. PubMed ID: 17991853 [TBL] [Abstract][Full Text] [Related]
16. The cellular prion protein: biochemistry, topology, and physiologic functions. Griffoni C; Toni M; Spisni E; Bianco M; Santi S; Riccio M; Tomasi V Cell Biochem Biophys; 2003; 38(3):287-304. PubMed ID: 12794269 [TBL] [Abstract][Full Text] [Related]
17. A transmembrane form of the prion protein in neurodegenerative disease. Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375 [TBL] [Abstract][Full Text] [Related]
18. Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases. Rossetti G; Cong X; Caliandro R; Legname G; Carloni P J Mol Biol; 2011 Aug; 411(3):700-12. PubMed ID: 21689662 [TBL] [Abstract][Full Text] [Related]
19. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants. Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887 [TBL] [Abstract][Full Text] [Related]